CLIFTON FULLER to Diffusion Magnetic Resonance Imaging
This is a "connection" page, showing publications CLIFTON FULLER has written about Diffusion Magnetic Resonance Imaging.
Connection Strength
0.758
-
Prospective evaluation of in vivo and phantom repeatability and reproducibility of diffusion-weighted MRI sequences on 1.5?T MRI-linear accelerator (MR-Linac) and MR simulator devices for head and neck cancers. Radiother Oncol. 2023 08; 185:109717.
Score: 0.189
-
Prospective validation of diffusion-weighted MRI as a biomarker of tumor response and oncologic outcomes in head and neck cancer: Results from an observational biomarker pre-qualification study. Radiother Oncol. 2023 06; 183:109641.
Score: 0.187
-
Changes in Apparent Diffusion Coefficient (ADC) in Serial Weekly MRI during Radiotherapy in Patients with Head and Neck Cancer: Results from the PREDICT-HN Study. Curr Oncol. 2022 08 31; 29(9):6303-6313.
Score: 0.180
-
Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation. Int J Radiat Oncol Biol Phys. 2017 03 01; 97(3):546-553.
Score: 0.121
-
Quality assurance assessment of intra-acquisition diffusion-weighted and T2-weighted magnetic resonance imaging registration and contour propagation for head and neck cancer radiotherapy. Med Phys. 2023 Apr; 50(4):2089-2099.
Score: 0.046
-
Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer. Radiother Oncol. 2019 06; 135:58-64.
Score: 0.035